Cargando…
Long, Noncoding RNA Dysregulation in Glioblastoma
SIMPLE SUMMARY: Developing effective therapies for glioblastoma (GBM), the most common primary brain cancer, remains challenging due to the heterogeneity within tumors and therapeutic resistance that drives recurrence. Noncoding RNAs are transcribed from a large proportion of the genome and remain l...
Autores principales: | DeSouza, Patrick A., Qu, Xuan, Chen, Hao, Patel, Bhuvic, Maher, Christopher A., Kim, Albert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037018/ https://www.ncbi.nlm.nih.gov/pubmed/33807183 http://dx.doi.org/10.3390/cancers13071604 |
Ejemplares similares
-
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma
por: Mahlokozera, Tatenda, et al.
Publicado: (2021) -
Long noncoding RNA dysregulation in ischemic heart failure
por: Greco, Simona, et al.
Publicado: (2016) -
Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma
por: Li, Junyang, et al.
Publicado: (2018) -
Identification of a long noncoding RNA signature to predict outcomes of glioblastoma
por: Li, Depei, et al.
Publicado: (2019) -
Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer
por: Zhong, Yancheng, et al.
Publicado: (2016)